This inventor holds 1 USPTO granted patent. Top assignees: Beihang University, Beijing Information Science & Technology University, Beijing Institute of Technology. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2025
Title: Innovations of Shirong Wang in Radiotherapy Technology.
Introduction
Shirong Wang is a notable inventor based in Beijing, CN. He has made significant contributions to the field of radiotherapy, particularly through his innovative patent that enhances treatment accuracy. His work is essential in advancing medical technology and improving patient outcomes.
Latest Patents
One of Shirong Wang's key patents is the "Image guided radiotherapy apparatus and control method therefor." This invention provides an advanced radiotherapy apparatus that includes a treatment unit with a treatment head for generating radiation beams. Additionally, it features an imaging unit that is integrated with the treatment head, allowing for precise imaging of the target area of a patient. This apparatus is applicable to both extracorporeal and intraoperative radiotherapy, ensuring high accuracy in treatment.
Career Highlights
Shirong Wang's career is marked by his dedication to improving radiotherapy techniques. His innovative approach has led to the development of technologies that significantly enhance the effectiveness of cancer treatments. With a focus on precision and patient care, he continues to be a driving force in the medical technology sector.
Collaborations
Shirong Wang has collaborated with esteemed colleagues such as Jianrong Dai and Chuanmeng Niu. These partnerships have fostered a collaborative environment that promotes innovation and the sharing of ideas in the field of radiotherapy.
Conclusion
Shirong Wang's contributions to radiotherapy technology exemplify the impact of innovation in healthcare. His patented inventions are paving the way for more effective cancer treatments, ultimately benefiting patients worldwide.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile